Bio-Techne corporation is a verified supplier
Bio-Techne corporation manufactures this product
Structured Review
Bio-Techne corporation
cleaved caspase3Cleaved Caspase3, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/cleaved caspase3/product/Bio-Techne corporation
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
cleaved caspase3 - by
Bioz Stars,
2024-09
93/100 stars
Images
haltrich 2007 thermus sp
(ATCC)
ATCC is a verified supplier
ATCC manufactures this product
Structured Review
ATCC
haltrich 2007 thermus spHaltrich 2007 Thermus Sp, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/haltrich 2007 thermus sp/product/ATCC
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
haltrich 2007 thermus sp - by
Bioz Stars,
2024-09
92/100 stars
Images
Bio-Techne corporation is a verified supplier
Bio-Techne corporation manufactures this product
Structured Review
Bio-Techne corporation
cleaved caspase3Cleaved Caspase3, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/cleaved caspase3/product/Bio-Techne corporation
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
cleaved caspase3 - by
Bioz Stars,
2024-09
93/100 stars
Images
Thermo Fisher is a verified supplier
Thermo Fisher manufactures this product
Structured Review
Thermo Fisher
emd 15840Emd 15840, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/emd 15840/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
emd 15840 - by
Bioz Stars,
2024-09
86/100 stars
Images
haltrich 2007 thermus sp
(ATCC)
ATCC is a verified supplier
ATCC manufactures this product
Structured Review
ATCC
haltrich 2007 thermus spHaltrich 2007 Thermus Sp, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/haltrich 2007 thermus sp/product/ATCC
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
haltrich 2007 thermus sp - by
Bioz Stars,
2024-09
92/100 stars
Images
Novus Biologicals is a verified supplier
Novus Biologicals manufactures this product
Structured Review
Novus Biologicals
rabbit polyclonal anti cdh1Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in
Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in
Figure 1 A. For comparison, see
Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in
Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="250" height="auto" />
Rabbit Polyclonal Anti Cdh1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/rabbit polyclonal anti cdh1/product/Novus Biologicals
Average 91 stars, based on 1 article reviews
Price from $9.99 to $1999.99
rabbit polyclonal anti cdh1 - by
Bioz Stars,
2024-09
91/100 stars
Images
1) Product Images from "TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells"
Article Title: TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells
Journal: iScience
doi: 10.1016/j.isci.2021.103675
Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in
Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in
Figure 1 A. For comparison, see
Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in
Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " title="APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of ..." property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset.
Techniques Used: Western Blot, Plasmid Preparation, Marker, Two Tailed Test, Incubation, Activation Assay
Figure 2 E. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (B and C) Cells of strains SCU69 (CEN4-GFP) and SCU3204 (CEN4-GFP cdc14-1) preincubated at 25°C were arrested in metaphase by nocodazole treatment for 3 h and then transferred to 37°C for 30 min. Thereafter, the cells were further incubated with or without rapamycin for 1 h. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids are shown in (C). For the control, cells were observed 30 min after nocodazole removal. Averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p < 0.05; ∗∗; p < 0.0001. (D and E) Cells of strain SCU1000 (CDC14-5GFP) were treated as described in
Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with diffused Cdc14 were determined and averages and SD from three independent experiments are shown in (E). For the control, cells were observed 30 min after nocodazole removal. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗∗∗∗, p <0.000001. (F) Five-fold serial dilutions of cells of strains SCU893 (wild type) and SCU1001 (cdc14-1) were spotted in 1-μL drops onto YPAD plates with or without 10 ng/mL rapamycin. The plates were incubated at 25°C for 3 days. An unrelated atg1Δ strain (SCU4067) defective in autophagy was used as the control. (G) Model of Cdc14 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset. " title="... The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset. " property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: Cdc14 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU3250 (PDS1-3HA cdc14-1) were treated as described in Figure 2 E. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (B and C) Cells of strains SCU69 (CEN4-GFP) and SCU3204 (CEN4-GFP cdc14-1) preincubated at 25°C were arrested in metaphase by nocodazole treatment for 3 h and then transferred to 37°C for 30 min. Thereafter, the cells were further incubated with or without rapamycin for 1 h. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids are shown in (C). For the control, cells were observed 30 min after nocodazole removal. Averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p < 0.05; ∗∗; p < 0.0001. (D and E) Cells of strain SCU1000 (CDC14-5GFP) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with diffused Cdc14 were determined and averages and SD from three independent experiments are shown in (E). For the control, cells were observed 30 min after nocodazole removal. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗∗∗∗, p <0.000001. (F) Five-fold serial dilutions of cells of strains SCU893 (wild type) and SCU1001 (cdc14-1) were spotted in 1-μL drops onto YPAD plates with or without 10 ng/mL rapamycin. The plates were incubated at 25°C for 3 days. An unrelated atg1Δ strain (SCU4067) defective in autophagy was used as the control. (G) Model of Cdc14 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset.
Techniques Used: Western Blot, Incubation, Two Tailed Test, Activation Assay
Figure S4 A is shown. Numbers show elapsed time (hour:minute) relative to the start of imaging. Scale bar, 50 μm. (C) Fate of nocodazole-treated A549 cells with or without rapamycin treatment after 60-h imaging. Proportion of cells classified into each category, obtained by averaging the results of four independent experiments shown in
Figure S4 A, is presented. Error bars represent standard errors. (D) Rate of mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage among the cells that underwent mitotic cell death or mitotic slippage, obtained by averaging the results of four independent experiments that are shown as dots, is presented. Error bars represent standard errors. ∗∗, p <0.01; ∗∗∗, p <0.001 (Tukey's multiple comparison test). ns, not statistically significant. (E) Duration of mitosis in nocodazole-treated A549 cells that underwent mitotic cell death or mitotic slippage. The results are average of four independent experiments. The results of rare mitotic slippage events in cells depleted of Cdc20 with or without Cdh1 were not shown. Error bars represent standard errors. ∗∗∗, p <0.001 (Tukey's multiple comparison test, comparison with Mock -Rap, mitotic cell death). (F) Duration of interphase after mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. The results are average of four independent experiments, which are shown as dots. Error bars represent standard errors. ∗∗, p <0.01 (Tukey's multiple comparison test). ns, not statistically significant. " title="... A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage ..." property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: mTORC1 inactivation elicits mitotic slippage (A) A schematic of the experimental procedure. (B) Phase-contrast time-lapse imaging of nocodazole-treated A549 cells. An example representing each category of cell fate to classify cells in Figure S4 A is shown. Numbers show elapsed time (hour:minute) relative to the start of imaging. Scale bar, 50 μm. (C) Fate of nocodazole-treated A549 cells with or without rapamycin treatment after 60-h imaging. Proportion of cells classified into each category, obtained by averaging the results of four independent experiments shown in Figure S4 A, is presented. Error bars represent standard errors. (D) Rate of mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage among the cells that underwent mitotic cell death or mitotic slippage, obtained by averaging the results of four independent experiments that are shown as dots, is presented. Error bars represent standard errors. ∗∗, p <0.01; ∗∗∗, p <0.001 (Tukey's multiple comparison test). ns, not statistically significant. (E) Duration of mitosis in nocodazole-treated A549 cells that underwent mitotic cell death or mitotic slippage. The results are average of four independent experiments. The results of rare mitotic slippage events in cells depleted of Cdc20 with or without Cdh1 were not shown. Error bars represent standard errors. ∗∗∗, p <0.001 (Tukey's multiple comparison test, comparison with Mock -Rap, mitotic cell death). (F) Duration of interphase after mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. The results are average of four independent experiments, which are shown as dots. Error bars represent standard errors. ∗∗, p <0.01 (Tukey's multiple comparison test). ns, not statistically significant.
Figure Legend Snippet:
Techniques Used: Recombinant, Western Blot, Sequencing, Plasmid Preparation, Software
Structured Review
Addgene inc
pypq144Pypq144, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/pypq144/product/Addgene inc
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
pypq144 - by
Bioz Stars,
2024-09
92/100 stars
Images
Structured Review
Addgene inc
pypq145Pypq145, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/pypq145/product/Addgene inc
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
pypq145 - by
Bioz Stars,
2024-09
92/100 stars
Images
Structured Review
Addgene inc
pypq141 zmubi rz aacPypq141 Zmubi Rz Aac, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/pypq141 zmubi rz aac/product/Addgene inc
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
pypq141 zmubi rz aac - by
Bioz Stars,
2024-09
92/100 stars
Images
Structured Review
Addgene inc
pypq143Pypq143, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/pypq143/product/Addgene inc
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
pypq143 - by
Bioz Stars,
2024-09
92/100 stars
Images
Structured Review
Addgene inc
pypq141Pypq141, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/pypq141/product/Addgene inc
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
pypq141 - by
Bioz Stars,
2024-09
92/100 stars
Images
Structured Review
Addgene inc
pypq146Pypq146, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/pypq146/product/Addgene inc
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
pypq146 - by
Bioz Stars,
2024-09
92/100 stars
Images
Novus Biologicals is a verified supplier
Novus Biologicals manufactures this product
Structured Review
Novus Biologicals
rabbit polyclonal anti cdh1Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in
Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in
Figure 1 A. For comparison, see
Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in
Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="250" height="auto" />
Rabbit Polyclonal Anti Cdh1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/result/rabbit polyclonal anti cdh1/product/Novus Biologicals
Average 91 stars, based on 1 article reviews
Price from $9.99 to $1999.99
rabbit polyclonal anti cdh1 - by
Bioz Stars,
2024-09
91/100 stars
Images
1) Product Images from "TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells"
Article Title: TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells
Journal: iScience
doi: 10.1016/j.isci.2021.103675
Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in
Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in
Figure 1 A. For comparison, see
Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in
Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " title="APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of ..." property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset.
Techniques Used: Western Blot, Plasmid Preparation, Marker, Two Tailed Test, Incubation, Activation Assay
Figure 2 E. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (B and C) Cells of strains SCU69 (CEN4-GFP) and SCU3204 (CEN4-GFP cdc14-1) preincubated at 25°C were arrested in metaphase by nocodazole treatment for 3 h and then transferred to 37°C for 30 min. Thereafter, the cells were further incubated with or without rapamycin for 1 h. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids are shown in (C). For the control, cells were observed 30 min after nocodazole removal. Averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p < 0.05; ∗∗; p < 0.0001. (D and E) Cells of strain SCU1000 (CDC14-5GFP) were treated as described in
Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with diffused Cdc14 were determined and averages and SD from three independent experiments are shown in (E). For the control, cells were observed 30 min after nocodazole removal. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗∗∗∗, p <0.000001. (F) Five-fold serial dilutions of cells of strains SCU893 (wild type) and SCU1001 (cdc14-1) were spotted in 1-μL drops onto YPAD plates with or without 10 ng/mL rapamycin. The plates were incubated at 25°C for 3 days. An unrelated atg1Δ strain (SCU4067) defective in autophagy was used as the control. (G) Model of Cdc14 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset. " title="... The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset. " property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: Cdc14 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU3250 (PDS1-3HA cdc14-1) were treated as described in Figure 2 E. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (B and C) Cells of strains SCU69 (CEN4-GFP) and SCU3204 (CEN4-GFP cdc14-1) preincubated at 25°C were arrested in metaphase by nocodazole treatment for 3 h and then transferred to 37°C for 30 min. Thereafter, the cells were further incubated with or without rapamycin for 1 h. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids are shown in (C). For the control, cells were observed 30 min after nocodazole removal. Averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p < 0.05; ∗∗; p < 0.0001. (D and E) Cells of strain SCU1000 (CDC14-5GFP) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with diffused Cdc14 were determined and averages and SD from three independent experiments are shown in (E). For the control, cells were observed 30 min after nocodazole removal. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗∗∗∗, p <0.000001. (F) Five-fold serial dilutions of cells of strains SCU893 (wild type) and SCU1001 (cdc14-1) were spotted in 1-μL drops onto YPAD plates with or without 10 ng/mL rapamycin. The plates were incubated at 25°C for 3 days. An unrelated atg1Δ strain (SCU4067) defective in autophagy was used as the control. (G) Model of Cdc14 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset.
Techniques Used: Western Blot, Incubation, Two Tailed Test, Activation Assay
Figure S4 A is shown. Numbers show elapsed time (hour:minute) relative to the start of imaging. Scale bar, 50 μm. (C) Fate of nocodazole-treated A549 cells with or without rapamycin treatment after 60-h imaging. Proportion of cells classified into each category, obtained by averaging the results of four independent experiments shown in
Figure S4 A, is presented. Error bars represent standard errors. (D) Rate of mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage among the cells that underwent mitotic cell death or mitotic slippage, obtained by averaging the results of four independent experiments that are shown as dots, is presented. Error bars represent standard errors. ∗∗, p <0.01; ∗∗∗, p <0.001 (Tukey's multiple comparison test). ns, not statistically significant. (E) Duration of mitosis in nocodazole-treated A549 cells that underwent mitotic cell death or mitotic slippage. The results are average of four independent experiments. The results of rare mitotic slippage events in cells depleted of Cdc20 with or without Cdh1 were not shown. Error bars represent standard errors. ∗∗∗, p <0.001 (Tukey's multiple comparison test, comparison with Mock -Rap, mitotic cell death). (F) Duration of interphase after mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. The results are average of four independent experiments, which are shown as dots. Error bars represent standard errors. ∗∗, p <0.01 (Tukey's multiple comparison test). ns, not statistically significant. " title="... A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage ..." property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: mTORC1 inactivation elicits mitotic slippage (A) A schematic of the experimental procedure. (B) Phase-contrast time-lapse imaging of nocodazole-treated A549 cells. An example representing each category of cell fate to classify cells in Figure S4 A is shown. Numbers show elapsed time (hour:minute) relative to the start of imaging. Scale bar, 50 μm. (C) Fate of nocodazole-treated A549 cells with or without rapamycin treatment after 60-h imaging. Proportion of cells classified into each category, obtained by averaging the results of four independent experiments shown in Figure S4 A, is presented. Error bars represent standard errors. (D) Rate of mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage among the cells that underwent mitotic cell death or mitotic slippage, obtained by averaging the results of four independent experiments that are shown as dots, is presented. Error bars represent standard errors. ∗∗, p <0.01; ∗∗∗, p <0.001 (Tukey's multiple comparison test). ns, not statistically significant. (E) Duration of mitosis in nocodazole-treated A549 cells that underwent mitotic cell death or mitotic slippage. The results are average of four independent experiments. The results of rare mitotic slippage events in cells depleted of Cdc20 with or without Cdh1 were not shown. Error bars represent standard errors. ∗∗∗, p <0.001 (Tukey's multiple comparison test, comparison with Mock -Rap, mitotic cell death). (F) Duration of interphase after mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. The results are average of four independent experiments, which are shown as dots. Error bars represent standard errors. ∗∗, p <0.01 (Tukey's multiple comparison test). ns, not statistically significant.
Figure Legend Snippet:
Techniques Used: Recombinant, Western Blot, Sequencing, Plasmid Preparation, Software